<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39434957</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2475-0379</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Research and practice in thrombosis and haemostasis</Title><ISOAbbreviation>Res Pract Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Fibrinaloid microclots in long COVID: assessing the actual evidence properly.</ArticleTitle><Pagination><StartPage>102566</StartPage><MedlinePgn>102566</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102566</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rpth.2024.102566</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kell</LastName><ForeName>Douglas B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Centre for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, Matieland, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>M Asad</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Directorate of Respiratory Medicine, Manchester University Hospitals, Wythenshawe Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretorius</LastName><ForeName>Etheresia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, Matieland, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Res Pract Thromb Haemost</MedlineTA><NlmUniqueID>101703775</NlmUniqueID><ISSNLinking>2475-0379</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39434957</ArticleId><ArticleId IdType="pmc">PMC11491705</ArticleId><ArticleId IdType="doi">10.1016/j.rpth.2024.102566</ArticleId><ArticleId IdType="pii">S2475-0379(24)00261-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hunt B.J., Kuehn R., Fox T., Carson A., Scandrett K., Davey Smith G., et al. Challenging the current hypothesis that thrombosis is responsible for the post-COVID-19 condition. Res Pract Thromb Haemost. 2024;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11186963</ArticleId><ArticleId IdType="pubmed">38903154</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20:172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Mbotwe S., Bester J., Robinson C.J., Kell D.B. Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide. J&#xa0;R Soc Interface. 2016;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5046953</ArticleId><ArticleId IdType="pubmed">27605168</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Page M.J., Hendricks L., Nkosi N.B., Benson S.R., et al. Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel Amytracker&#x2122; stains. J&#xa0;R Soc Interface. 2018;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5832738</ArticleId><ArticleId IdType="pubmed">29445039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting. Prog Biophys Mol Biol. 2017;123:16&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">27554450</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. Are fibrinaloid microclots a cause of autoimmunity in long COVID and other post-infection diseases? Biochem J. 2023;480:1217&#x2013;1240.</Citation><ArticleIdList><ArticleId IdType="pubmed">37584410</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S.O., Watson L.R., et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID/post-acute sequelae of COVID-19 (PASC) Cardiovasc Diabetol. 2022;21:148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab. 2023;34:321&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Laubscher G.J., Khan M.A., Kell D.B., Pretorius E. Accelerating discovery: a novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model. Heliyon. 2023;9 doi: 10.1016/j.heliyon.2023.e19605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e19605</ArticleId><ArticleId IdType="pmc">PMC10558872</ArticleId><ArticleId IdType="pubmed">37809592</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., Venter C., Vlok M., Ngoepe M., Laubscher G.J., Lourens P.J., et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci Rep. 2021;41</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu J.K., Yan Z., Montano M., Sozmen E.G., Dixit K., Suryawanshi R.K., et al. Fibrin drives thromboinflammation and neuropathology in COVID-19. Nature. 2024;633:905&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11424477</ArticleId><ArticleId IdType="pubmed">39198643</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofield J., Abrams S.T., Jenkins R., Lane S., Wang G., Toh C.H. Microclots, as defined by amyloid-fibrinogen aggregates, predict risks of disseminated intravascular coagulation and mortality May 28. 2024;8(10):2499&#x2013;2508. doi: 10.1182/bloodadvances.2023012473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2023012473</ArticleId><ArticleId IdType="pmc">PMC11131067</ArticleId><ArticleId IdType="pubmed">38507683</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>